Ciliary neurotrophic factor restores gallbladder contractility in leptin-resistant obese diabetic mice

Journal of Surgical Research

Volumn 130, Issue 1, 2006, Pages 146-151

  Graewin, Shannon J ^a   Kiely, James M ^a   Svatek, Carol L ^a   Pitt, Henry A ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesterol; Diabetes mellitus; Gallbladder; Gallstones; Motility

Indexed keywords

ACETYLCHOLINE; CHOLECYSTOKININ; CILIARY NEUROTROPHIC FACTOR; FAT; INSULIN; LEPTIN; NEUROPEPTIDE Y;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DIABETIC OBESITY; FEMALE; GALLBLADDER CONTRACTION; GALLBLADDER MOTILITY; GLUCOSE BLOOD LEVEL; LEAN BODY WEIGHT; LIVER; LIVER WEIGHT; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; WEIGHT REDUCTION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CILIARY NEUROTROPHIC FACTOR; DIABETES MELLITUS, TYPE 2; FEMALE; GALLBLADDER; GALLBLADDER EMPTYING; INSULIN; LEPTIN; LIVER; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, OBESE; MUSCLE CONTRACTION; OBESITY; ORGAN SIZE; VACUOLES;

EID: 29744432224     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.07.032     Document Type: Article

References (28)

1. A.H. Mokdad, E.S. Ford, B.A. Bowman Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 2003 76
2. E. Jequier Leptin signaling, adiposity, and energy balance Ann. NY Acad. Sci. 967 2002 379
3. M.I. Goldblatt, D.A. Swartz-Basile, C.L. Svatek, A. Nakeeb, H.A. Pitt Decreased gallbladder response in leptin-deficient obese mice J. Gastrointest. Surg. 6 2002 438
4. K.Q. Tran, D.A. Swartz-Basile, A. Nakeeb, H.A. Pitt Gallbladder motility in Agouti-yellow and leptin-resistant obese mice J. Surg. Res. 113 2003 56
5. K.Q. Tran, M.I. Goldblatt, D.A. Swartz-Basile, C.L. Svatek, A. Nakeeb, H.A. Pitt Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity J. Gastrointest. Surg. 7 2003 857
6. J. Phillips, K.Q. Tran, M.I. Goldblatt, D.A. Swartz-Basile, A. Nakeeb, H.A. Pitt Leptin ameliorates the gallbladder's response to neurotransmitters in congenitally obese mice Gastroenterol 123 2002 9A
7. M. Van Heek, D.S. Compton, C.F. France Diet-induced obese mice develop peripheral, but not central, resistance to leptin J. Clin. Invest. 99 1997 385
8. S.B. Heymsfield, A.S. Greenberg, K. Fujioka Recombinant leptin for weight loss in obese and lean adults a randomized, controlled, dose escalation trial JAMA 282 1999 1568
9. P.D. Lambert, K.D. Anderson, M.W. Sleeman Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat without cachexia or rebound weight gain, even in leptin-resistant obesity PNAS 98 2001 4652
10. M.W. Sleeman, K. Garcia, J.D. Murray Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rates in db/db mice PNAS 100 2003 14297
11. ALS CNTF Treatment Study Group A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rH-CNTF) in amylotrophic lateral sclerosis Neurology 46 1996 1244
12. M.W. Sleeman, K.D. Anderson, P.D. Lambert, G.D. Yancopoulos, S.J. Wiegand The ciliary neurotrophic factor and its receptor CNTFR alpha Parm. Acta Helv. 74 2000 265
13. D.A. Swartz-Basile, S.J. Graewin, C.L. Svatek, H.A. Pitt Alimentary leptin receptors are most abundant in the gallbladder J. Am. Coll. Surg. 199 2004 512
14. B. Xu, M.G. Dube, P.S. Kalra Anorectic effects of the cytokine, ciliary neurotrophic factor, are mediated by hypothalamic neuropeptide Y Comparison with leptin J. Neuroendocrinol. 12 2000 827
15. G. Bouchard, D. Johnson, T. Carver, B. Paigen, M.C. Carey Cholesterol gallstone formation in overweight mice establishes that obesity per se is not linked directly to cholelithiasis risk J. Lipid Res. 43 2002 1105
16. S.J. Graewin, J.M. Kiely, K. Lee, C.L. Svatek, A. Nakeeb, H.A. Pitt Non-obese diabetic mice have diminished gallbladder motility and shortened crystal observation time J. Gastrointest. Surg. 8 2004 824
17. J.R. Grider Role of cholecystokinin in the regulation of gastrointestinal motility J. Nutr. 124 1994 1334S
18. P. Yu, Q. Chen, Z. Xiao, K. Harnett, P. Biancani, J. Behar Signal transduction pathways mediating CCK-induced gallbladder muscle contraction Am. J. Physiol. 275 1998 G203
19. G.M. Mawe, E.K. Talmage, E.B. Cornbrooks, A.P. Gokin, L. Zhang, L.J. Jennings Innervation of the gallbladder Structure, neurochemical coding, and physiological properties of guinea pig gallbladder ganglia Micro. Res. Tech. 39 1997 1
20. R. Singh, A. Barden, T. Mori, L. Beilin Advanced glycation end-products A review Diabetologia 44 2001 129
21. S.J. Graewin, K.-H. Lee, J.M. Kiely, C.L. Svatek, A. Nakeeb, H.A. Pitt Gallbladder myocytes are short and CCK-resistant in obese diabetic mice Surgery 136 2004 431
22. R. Bucala Lipid and lipoprotein modification by AGE's Role in atherosclerosis Exp. Physiol. 82 1997 327
23. P. Yu, Q. Chen, K.M. Harnett, J. Amaral, P. Biancani, J. Behar Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones Am. J. Physiol. 269 1995 G659
24. Q. Chen, J. Amaral, P. Biancani, J. Behar Excess membrane cholesterol alters human gallbladder muscle contraction and membrane fluidity Gastroenterology 116 1999 678
25. M.I. Goldblatt, D.A. Swartz-Basile, H.A. Al-Azzawi, K.Q. Tran, A. Nakeeb, H.A. Pitt Nonalcoholic fatty gallbladder disease The influence of diet in lean and obese mice J. Gastrointest. Surg. 2006 (in press)
26. S.J. Graewin, K. Lee, K.Q. Tran Leptin-resistant obese mice do not form biliary crystals on a high cholesterol diet J. Surg. Res. 12 2004 145
27. K.Q. Tran, S.J. Graewin, D.A. Swartz-Basile, A. Nakeeb, C.L. Svatek, H.A. Pitt Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation Surgery 134 2003 372
28. I.J. Jonkers, A.H. Smelt, M. Ledeboer Gallbladder dysmotility A risk factor for gallstone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil Gut 52 2003 109